NCT05324124View on ClinicalTrials.gov

A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

June 22, 2022

Study Completion Date

June 22, 2022

Conditions
Healthy
Interventions
DRUG

Selpercatinib

Administered orally.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Loxo Oncology, Inc.

INDUSTRY

NCT05324124 - A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participants | Biotech Hunter | Biotech Hunter